IVIG Treatment and Prognosis in Guillain–Barré Syndrome

INTRODUCTION: Guillain–Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy that often leads to severe weakness. Intravenous immunoglobulin (IVIG) is a proven effective treatment for GBS (class 1 evidence). However, about 25% of patients need artificial ventilation and 20% are still unab...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: van Doorn, Pieter A., Kuitwaard, Krista, Walgaard, Christa, van Koningsveld, Rinske, Ruts, Liselotte, Jacobs, Bart C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2883091/
https://ncbi.nlm.nih.gov/pubmed/20396937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-010-9407-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi